Neurosearch A/S Announces Changes In The Executive Board And Board Of Directors And Informs Of An EGM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

As announced in late July 2013, René Schneider will resign from the position as CEO of NeuroSearch A/S (NEUR) as of 30 November 2013. The Board of Directors has decided to appoint the present Chairman of the Board of Directors, Allan Andersen, as new CEO as of 1 December 2013. It is agreed, until further notice, that the position will be a part-time position. After careful consideration, the Board of Directors has concluded that this solution will be the best way to safeguard the interests of the company in a financially sound manner in the coming period when the company’s freedom of action will be restricted due to the coming criminal proceedings resulting from the indictment in July 2013 by the Public Prosecutor for Serious Economic and International Crime, see for example the recent 3rd quarter interim financial report.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC